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Abstract
Introduction: Bacteremia is recognized as a critical condition that influences the outcome of sepsis. Although
large-scale surveillance studies of bacterial species causing bacteremia have been published, the pathophysiological
differences in bacteremias with different causative bacterial species remain unclear. The objective of the present
study is to investigate the differences in pathophysiology and the clinical course of bacteremia caused by different
bacterial species.
Methods: We reviewed the medical records of all consecutive patients admitted to the general intensive care unit
(ICU) of a university teaching hospital during the eight-year period since introduction of a rapid assay for
interleukin (IL)-6 blood level to routine ICU practice in May 2000. White blood cell count, C-reactive protein (CRP),
IL-6 blood level, and clinical course were compared among different pathogenic bacterial species.
Results: The 259 eligible patients, as well as 515 eligible culture-positive blood samples collected from them, were
included in this study. CRP, IL-6 blood level, and mortality were significantly higher in the septic shock group (n =
57) than in the sepsis group (n = 127) (P < 0.001). The 515 eligible culture-positive blood samples harbored a total
of 593 isolates of microorganisms (Gram-positive, 407; Gram-negative, 176; fungi, 10). The incidence of Gram-
negative bacteremia was significantly higher in the septic shock group than in the sepsis group (P < 0.001) and in
the severe sepsis group (n = 75, P < 0.01). CRP and IL-6 blood level were significantly higher in Gram-negative
bacteremia (n = 176) than in Gram-positive bacteremia (n = 407) (P < 0.001, <0.0005, respectively).
Conclusions: The incidence of Gram-negative bacteremia was significantly higher in bacteremic ICU patients with
septic shock than in those with sepsis or severe sepsis. Furthermore, CRP and IL-6 levels were significantly higher in
Gram-negative bacteremia than in Gram-positive bacteremia. These findings suggest that differences in host
responses and virulence mechanisms of different pathogenic microorganisms should be considered in treatment of
bacteremic patients, and that new countermeasures beyond conventional antimicrobial medications are urgently
needed.
Introduction
Despite recent advances in critical care medicine, the
mortality of sepsis in ICU remains high [1,2]. Among
various infections underlying sepsis, bacteremia is recog-
nized as a critical condition that influences the outcome
of sepsis [3,4], and is reportedly associated with an attri-
butable mortality of approximately 35% [5]. While the
larger part of pathogens in sepsis-inducing infections
was previously Gram-negative bacteria, currently the lar-
ger part of pathogens identified in sepsis is Gram-posi-
tive bacteria [1,6], with an increasing proportion of
multi-resistant bacteria [7]. Although large-scale surveil-
lance studies of bacterial species causing bacteremia
have been published [7,8], the pathophysiological differ-
ences in bacteremias with different causative bacterial
species remain unclear.
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interleukin (IL)-6 blood level, aiming at real-time assess-
ment of the magnitude of inflammatory response to
facilitate prompt determination of disease severity and
therapeutic effects [9]. The objective of the present
study was to investigate differences in the pathophysio-
logy and clinical course of bacteremia caused by differ-
ent bacterial species by cross-check review of laboratory
findings and the clinical record with pathogenic micro-
bial species in bacteremic patients who were admitted
to the ICU during the eight years since introduction of
the rapid IL-6 assay to routine ICU practice.
Materials and methods
Study population
We reviewed the medical records of all consecutive
patients admitted to the general ICU of a university
teaching hospital during the period from May 2000 to
October 2008. Patients with one or more blood samples
processed for culture were enrolled in the study. Among
culture-positive patients, those fulfilling diagnostic cri-
teria for sepsis described below and undergoing blood
sampling for measurement of white blood cell count
(WBC), C-reactive protein (CRP), and IL-6 concomi-
tantly with collection of blood culture samples were
finally included in the extensive review described below
(see Figure 1). Informed consent for blood sampling as
a part of daily practice and later use of the data for aca-
demic purpose was obtained from all patients or their
family members when the patients were admitted to the
ICU. The study was approved by the institutional ethics
committee.
For the diagnosis of sepsis, the criteria of the Ameri-
can College of Chest Physicians/Society of Critical Care
Medicine Consensus Conference were applied [10]. The
criteria were as follows. Fulfillment of both of the fol-
l o w i n g ,( 1 )a n d( 2 ) ,w a sr e q u i r e d :( 1 )T h ep r e s e n c eo f
systemic inflammatory response syndrome (manifested
by two or more of the following criteria: fever (tempera-
ture above 38°C) or hypothermia (temperature below
35.5°C), tachycardia (more than 90 beats per minute),
tachypnea (more than 20 breaths per minute), or hypo-
capnia (PaCO2 of less than 32 torr), and leukocytosis or
leukopenia (white blood cell count of more than 12,000/
mm
3 or less than 4,000/mm
3, respectively)); (2) a docu-
mented source of infection.
Among patients meeting the diagnostic criteria for
sepsis described above, those also meeting at least one
of the following criteria for organ failure were classified
in the severe sepsis group: hypoxemia (PaO2/FiO2 <
300), acute oliguria (urine output <0.5 mL/kg/hr persist-
ing two hours or longer), serum creatinine >2.0 mg/dL,
coagulation disorder (PT-INR > 1.5), thrombocytopenia
(PLT < 100,000/mL), hyperbilirubinemia (T-Bil > 2.0
Figure 1 Selection of eligible patients and blood culture samples. Patients were admitted to the ICU between May 2000 and October 2008.
SIRS: systemic inflammatory response syndrome.
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Page 2 of 7mg/dL), and hyperlactatemia (blood lactate >18 mg/dL).
Of those in the severe sepsis group, those with a systolic
pressure of 90 mmHg or lower that persisted despite
appropriate fluid resuscitation and required a vasopres-
s o rw e r ec l a s s i f i e di nt h es e p t i cs h o c kg r o u p .T h e
remaining patients classified in neither the severe sepsis
nor the septic shock group comprised the sepsis group.
Patients with hematological malignancies and autoim-
mune disorders who needed treatment of immunosup-
pressive drug therapy were excluded from the present
study. Immunosuppressive drugs include predonisolone,
methylpredonisolone, cyclophosphamide, cyclosporine,
doxorubicin, vincristine, methotrexate, rituximab and
FK506. Patients with positive blood culture but not
meeting the diagnostic criteria for sepsis were also
excluded from the study to eliminate the possibility of
samples false-positive as a result of contamination. Sam-
ples collected through central venous catheter and sam-
ples collected through peripheral vein puncture were
excluded from the study to eliminate the possible var-
iance of blood levels of biomarkers between arterial
blood and venous blood. Patients whose blood culture
showed skin indigenous bacteria in only one of the
duplicate samples were also excluded. Coagulase-nega-
tive Staphylococcus, Corynebacterium species, Micro-
coccus species and Propionibacterium species were
defined as skin indigenous bacteria.
Blood culture
Blood culture samples were collected from arterial
catheters by ICU staff doctors. Before taking blood sam-
ples, catheter ports or stopcocks were disinfected with
povidone-iodone swab and 70% isopropyl alcohol swab.
A 10 mL blood sample was divided evenly into anaero-
bic and aerobic culture bottles at the bedside. Blood
samples were processed using a BACTEC 9240 auto-
mated blood culture system in combination with both
standard aerobic and anaerobic media available from the
instrument manufacturer (Becton Dickinson Diagnostic
Instrument Systems, Paramus, NJ, USA). Bacteria were
identified using standard methods. Two distinct episodes
of bloodstream infection were recorded for a patient,
regardless of bacterial species detected, if at least six
days had elapsed between the two positive blood cul-
tures, provided appropriate therapy had been implemen-
ted and significant clinical improvement had been
obtained between the two episodes.
Cytokine blood levels
Blood samples were obtained from arterial catheter
simultaneously with collection of culture samples in all
the patients studied. IL-6 blood levels were measured
with a chemiluminescence enzyme immunoassay using a
rapid measurement system (Human IL-6 CLEIA,
Fujirebio, Tokyo, Japan). The duration of processing for
IL-6 measurement was approximately 30 minutes [9].
Grouping of patients and blood culture samples
First, the three patient groups divided according to
severity of sepsis (sepsis, severe sepsis, and septic shock)
were compared for white blood count, CRP, and IL-6
blood level as well as mortality.
Culture-positive blood samples were divided into two
groups, Gram-positive (GP) sample group and Gram-
negative (GN) sample group, according to the bacterial
species detected. When both Gram-positive and Gram-
negative bacteria were detected in one blood culture
sample, the sample was included in both the GP and
G Ns a m p l eg r o u p s .W B C ,C R P ,a n dI L - 6b l o o dl e v e l s
were compared between these two sample groups.
Finally, all bacteremic patients were divided into three
groups according to bacterial species detected during
the clinical course: GP patients’ group, one or more
Gram-positive species detected; GN patients’ group, one
or more Gram-negative species detected; and GP/GN
patients’ group, both Gram-positive and Gram-negative
species detected. These three patient groups were com-
pared for severity and clinical outcome. Severity of ill-
ness was assessed by calculating Acute Physiology and
Chronic Health Evaluation (APACHE)-II score [11] and
Sequential Organ Failure Assessment (SOFA) score [12].
Statistical analysis
Comparisons of variables among groups were performed
with the unpaired Student’s t-test, except for sex, mor-
tality, and positivity for Gram-positive and Gram-nega-
tive bacteria, which were compared with the chi-square
test. Statistical significance was defined as P <0 . 0 5 .S t a -
tistical analyses were performed with the SPSS 13.0 J for
Windows software package (SPSS Inc, Chicago, IL,
USA).
Results
Between May 2000 and October 2008, 4,092 patients
were admitted to the ICU, and 2,528 of them underwent
blood culture tests. Positive blood culture was confirmed
for 743 of 4,191 samples submitted. After eliminating
those meeting the exclusion criteria the remaining 515
culture-positive samples were included in the present
study. These samples were collected from 259 patients
and harbored a total of 593 microorganism isolates
(Figure 1).
The 259 eligible patients included 127 patients in the
sepsis group, 75 patients in the severe sepsis group, and
57 patients in the septic shock group. Table 1 sum-
marizes background characteristics, WBC, CRP, and IL-
6 (measured concomitantly with collection of culture-
positive blood samples) as well as causative
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groups. Results demonstrated that CRP level was signifi-
cantly higher in the septic shock group than in the sep-
sis group. The IL-6 blood level was significantly higher
in the septic shock group than in the sepsis and in the
severe sepsis groups. Furthermore, mortality in the sep-
tic shock group was significantly higher than that in the
sepsis group. The incidence of Gram-positive bacteremia
in the septic shock group was significantly lower than
those in the two other patient groups, while the inci-
dence of Gram-negative bacteremia was significantly
higher in the septic shock group than in any other
group. The incidence of bacteremia caused by both
Gram-positive and Gram-negative bacteria was signifi-
cantly higher in the septic shock group than in the sep-
sis group; this was also the case for the incidence of
bacteremia caused by multiple organisms.
Table 2 compares patient characteristics, severity
scores, length of ICU stay and mortality among GP
patients’ group (n = 168), GN patients’ group (n = 70)
and GP/GN patients’ group (n = 15). APACHE II score
was significantly higher in the GN patients’ group than
in GP patients’ group, while no significant differences
were noted between any pair of groups examined.
The 515 eligible culture-positive blood samples har-
bored a total of 593 isolates of microorganisms,
including 407 isolates of Gram-positive bacteria, 176
isolates of Gram-negative bacteria, and 10 isolates of
fungi. Two or more different microbial species were
concomitantly detected in 60 blood culture samples. As
demonstrated in Figure 2, both CRP and IL-6 blood
level were significantly higher in the GN sample group.
Discussion
We reviewed medical records of septic patients admitted
to the ICU and being positive on blood culture during
the last eight years for comparison of background char-
acteristics, WBC, CRP, and IL-6 as well as causative
microorganisms and clinical outcome. When eligible
patients were classified into three groups by severity of
sepsis, the prevalence of Gram-negative bacteremia, pre-
valence of bacteremia caused by both Gram-positive and
Gram-negative bacteria, and IL-6 blood level were sig-
nificantly higher in the septic shock group than in either
of the other two groups (Table 1). When episodes of
bacteremia caused by Gram-positive and Gram-negative
bacteria were compared, CRP and IL-6 blood level were
found to be significantly higher in Gram-negative bac-
teremia (Figure 2). Notably, the sample size in the pre-
sent study (176 and 407 for episodes of Gram-negative
and Gram-positive bacteremia, respectively) is larger
than that in any other similar study published to date.
Table 1 Patients’ characteristics, white blood cell count, C-reactive protein and interleukin-6 blood level and mortality
Total
N = 259
Sepsis
N = 127
Severe sepsis
N=7 5
Septic shock
N=5 7
P value
Age yrs, mean (SD) 58.1
(18.6)
54.7
(18.6)
61.0
(17.3)
61.7
(19.2)
<0.05
a,
b
Male, n (%) 180
(69.5)
88
(69.3)
55
(73.3)
37
(64.9)
ns
WBC (*10
3/mm
3), mean (SD) 14.0
(9.5)
14.1
(8.1)
15.2
(10.9)
12.8
(11.0)
ns
CRP (mg/dL), mean (SD) 11.8
(9.1)
10.0
(8.5)
11.4
(9.3)
15.6
(9.5)
<0.001
b
IL-6 (pg/mL), mean (SD) 33,543
(136,974)
8,398
(47,705)
8,176
(37,975)
118,435
(264,819)
<0.001
b,
c
Gram positive bacteremia, n (%) 168
(64.9)
92
(72.4)
51
(68.0)
25
(43.9)
<0.0005
d
<0.01
e
Gram negative bacteremia, n (%) 70
(27.0)
28
(22.0)
17
(22.7)
25
(43.9)
<0.005
d
<0.01
e
Both of Gram positive and negative bacteremia*, n (%) 15
(5.8)
4
(3.1)
4
(5.3)
7
(12.3)
<0.05
d
Fungemia*, n (%) 7
(2.7)
3
(2.3)
3
(4.0)
1
(1.8)
ns
Bacteremia caused by multiple organisms, n (%) 16
(6.2)
4
(3.1)
4
(5.3)
8
(14.0)
<0.01
d
Length of ICU stay (day), mean (SD) 19.4
(21.7)
20.6
(22.4)
17.4
(17.7)
19.5
(24.9)
ns
Mortality (%) 31.3 20.5 36.0 49.1 <0.001
d
WBC, white blood cell count; CRP, C-reactive protein; IL-6, interleukin-6. *One case overlapping because Gram-positive bacteria and fungi were detected.
aWith
unpaired Student’s T test, between sepsis group and severe sepsis group.
bWith unpaired Student’s T test, between sepsis group and septic shock group.
c With
unpaired Student’s T test, between severe sepsis group and septic shock group.
d With Chi square test, between sepsis group and septic shock group.
e With Chi
square test, between severe sepsis group and septic shock group.
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depending on the type of pathogen, that is, the type of
pathogen-associated molecular patterns (PAMPs), have
been already recognized [13], few studies have examined
this difference quantitatively. While Fisher et al. [14]
previously reported that plasma IL-6 levels were signifi-
cantly higher in patients with Gram-negative bacteremia
(n = 17) than in those with Gram-positive bacteremia (n
= 12), the present study is, to the best of our knowledge,
the first demonstration of such differences in response
to bacterial bloodstream infection among different cau-
sative bacterial species in a sufficiently large study popu-
lation. Our finding that CRP and IL-6 blood level were
significantly higher in Gram-negative bacteremia than in
Gram-positive bacteremia suggests that different types
of PAMPs may induce different types and magnitudes of
response. Since IL-6 is not only an index of response to
invasion but also a typical alarmin [15], IL-6 per se may
induce further exacerbation of pathophysiological
condition.
The magnitude of biological response to insult has
been believed to be determined by the magnitude of
insult as well as host predisposition. This concept has
been schematized in the recently proposed PIRO model
(Predisposition, Insult, Response, and Organ dysfunc-
tion) [16]. When the PIRO model is applied to cases of
sepsis, the nature of insult can be considered infection,
with the site, type, and extent of infection significantly
Table 2 Patients’ characteristics, severity scores, length of ICU stay and mortality in GP, GN, GP/GN groups
GP patients’ group (n = 168) GN patients’ group (n = 70) GP/GN patients’ group (n = 15) P value
Age (yrs), mean (SD) 56.2 (18.9) 61.7 (17.2) 60.3 (21.0) ns
Male, n (%) 118 (70.2) 48 (68.6) 9 (60.0) ns
APACHE II, mean (SD) 21.8 (9.5) 24.6 (7.4) 23.6 (10.7) <0.05
a
SOFA, mean (SD) 9.53 (5.0) 10.71 (4.4) 11.66 (6.0) ns
Length of ICU stay (days), mean (SD) 18.7 (15.8) 20.5 (29.6) 16.2 (17.5) ns
Mortality, (%) 28.0 40.0 33.3 ns
GP, Gram-positive; GN, Gram-negative; GP/GN, Gram-positive and Gram-negative; APACHE-II, Acute Physiology and Chronic Health Evaluation-II; SOFA, Sequential
Organ Failure Assessment.
aWith Mann-Whitney’s U-test, between GP patients’ group and GN patients’ group.
Figure 2 WBC, CRP and IL-6 levels in GP sample group and GN sample group. Blood samples used for measurement of laboratory
parameters were collected concomitantly with sampling for blood culture. *P value calculated by Student’s t-test. CRP, C-reactive protein; GP,
gram-positive sample group; GN, gram-negative sample group; IL-6, interleukin-6; WBC, white blood cell count.
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the mechanisms of bacterial virulence vary depending
on bacterial species and strain [17]. For example, S. aur-
eus produces protein A, which is a ligand for tumor
necrosis factor (TNF) receptor-1 and induces a response
identical to that caused by TNF-a stimulation [18]. In
addition, some Group B Streptococcus strains produce
C5a peptidase to inhibit activation of the complement
system [19]. Differences in mechanisms of bacterial viru-
lence result in differences in host response, that is, dif-
ferences in the extent of activation of various signaling
cascades and stimulation/inhibition of host cell apopto-
sis [17,20], leading to influence prognosis.
Earlier initiation of appropriate antimicrobial therapy
is clearly crucial in the treatment of sepsis [21]. On the
other hand, though no countermeasures taking differ-
ences in the mechanisms of bacterial virulence into
account are currently available in clinical practice, anti-
microbial therapy beyond conventional antimicrobial
medications is urgently needed. Some recent studies
suggest future possibilities for such therapies. For exam-
ple, inhibition of quorum-sensing regulated genes of
Pseudomonas aeruginosa by synthetic furanones
improved survival in a mouse model of pneumonia [22].
Such virulence-targeting antimicrobial therapies are
expected to provide new options for the treatment of
sepsis in ICU [23].
PAMPs from Gram-negative and Gram-positive bac-
teria are known to act as ligands for mutually different
pattern recognition receptors including Toll-like recep-
tors [24], and the molecular mechanisms underlying the
differential responses to infection with Gram-negative
and Gram-positive bacteria have been investigated [25].
However, the effects of differences in the molecular
mechanisms of response to invasion of Gram-negative
and Gram-positive bacteria on the clinical course and
prognosis of sepsis require further clarification. In parti-
cular, IL-6 and CRP are known to be relatively non-spe-
cific biomarkers, compared with more validated
biomarkers for sepsis, such as procalcitonin and trigger-
ing receptors expressed on myeloid cell (TREM)-1. The
differences of blood levels of such non-specific biomar-
kers warrant further characterization at the molucular
level of the differences in virulence mechanisms between
Gram-negative and Gram-positive bacteremia.
The present study has the following limitations. First,
it was a retrospective study. Second, it was a single-cen-
ter study in which it is difficult to rule out the possibi-
lity of bias in bacterial species identified and in patients’
characteristics. In particular, the high percentage of
male patients (69.5%, Table 1) implies such possibility of
bias, even though this male-female ratio was consistent
with that of all patients admitted to our ICU during
eight years (63.3%, n = 4,092, male 2,590, female 1,502).
H o w e v e r ,t h es a m em a l ep r e d o m i n a n c ei nI C Up o p u l a -
tion was also noticed before, even though the reason for
this male predominance is unknown [26]. Length of
I C Us t a ya l s om i g h ts u g g e s tt h ee x i s t e n c eo fb i a s ,s i n c e
the three groups divided by severity of sepsis did not
show differences in length of stay. In addition to that,
since patients in the septic shock group and the severe
sepsis group were significantly older than the sepsis
group patients, those differences might affect the magni-
tude of inflammatory reactions and outcomes. Regarding
the severity of Gram-positive and Gram-negative patient
groups, SOFA score did not demonstrate the significant
difference between groups, though APACHE II score
did (Table 2). This result suggests that the number of
patients might not be enough to reach the conclusion.
Furthermore, because molecular mechanism of virulence
underlying the present findings is not yet clarified, these
results cannot be directly translated into practical man-
agement. Nevertheless, the present study has the merit
of having demonstrated differences in blood cytokine
levels in bacteremia caused by different bacterial species
in a study population larger than that of any of the
other similar studies.
Conclusions
Patients admitted to the ICU with bacteremia were clas-
sified according to severity of sepsis for comparison of
pathogenic microorganisms and blood levels of inflam-
matory biomarkers. The incidence of Gram-negative
bacteria and CRP and IL-6 blood level were significantly
higher in the septic shock group than in the sepsis and
severe sepsis groups. Furthermore, CRP and IL-6 blood
level measured concomitantly with sampling for blood
culture were significantly higher in Gram-negative bac-
teremia than in Gram-positive bacteremia. These find-
ings suggest that differences in host responses and
virulence mechanisms of different pathogenic microor-
ganisms should be considered in treatment of bactere-
mic patients, and that new countermeasures beyond
conventional antimicrobial medications are urgently
needed.
Key messages
￿ CRP and IL-6 blood level were significantly higher in
Gram-negative bacteremia than in Gram-positive
bacteremia.
￿ The incidence of Gram-negative bacteremia was sig-
nificantly higher in bacteremic ICU patients with septic
shock than in those with sepsis or severe sepsis.
￿ Characterization at the molecular level of the differ-
ences in virulence mechanisms between Gram-negative
and Gram-positive bacteria is required.
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